Merck and ISB Collaborate to Understand and Treat SARS-CoV-2 Infection
heath.isbscience.org/2020/04/27/merck-isb-covid/
heath.isbscience.org/2020/04/27/merck-isb-covid/ Recent Articles
-
Dr. Knatokie Ford Shares STEM Journey, Learnings and Advice in ISB-Town Hall Seattle Livestream
Dr. Knatokie Ford was the featured speaker of a virtual event hosted by ISB and Town Hall Seattle, and shared many of the experiences that helped pave her way to become a leading voice in STEM policy and advocacy, and identified several ways parents and teachers can encourage kids to become tomorrow’s STEM professionals.
-
ISB Builds Digital Platform for COVID-19 Research Study – and Beyond
In a multi-institutional study of a highly infectious disease like COVID-19, paperless consent for study participants is critical. One component of the COVID-19 Immune Response Study is a recruitment website with an IRB-approved and HIPAA-compliant electronic consent platform for enrolling patients.
-
For Cancer Cells, There Is More Than One Path to Drug Resistance
In findings published in the journal Nature Communications, researchers show that cancer cells can take more than one path to reach a drug-resistant cell state. These findings could have promising implications for the future of cancer care.